Myriad Genetics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of MYGN for the last quarter is 211.50 M USD, and it's 4.60% higher compared to the previous quarter. The net income of Q2 24 is -36.70 M USD.